Johnson & Johnson Innovation – Quick Pitch

Quick Pitch

At Johnson & Johnson, we believe a good idea can come from anywhere. Our aim is to identify, empower and enable the best ideas to get to patients and consumers around the globe. In an effort to unearth the unseen and brightest innovations in healthcare, Johnson & Johnson Innovation is launching a Quick Pitch event where innovators can apply to present to Johnson & Johnson Innovation's leadership during the week of the 37th Annual JP Morgan Healthcare Conference in San Francisco, CA.   If you are selected, you will have an opportunity to present for 5 minutes followed by a 5 minute Q&A session with Johnson & Johnson Innovation's leadership. 

If you have a novel idea that has yet to be introduced to Johnson & Johnson and fits our areas of interest, we would like to hear from you. Apply for an open spot at the Johnson & Johnson Innovation Quick Pitch event to be held on Wednesday, January 9th from 9-11am. Limited spots available.


Applications must be submitted by December 7th.   

Quick Pitch Recruitment Program

To enable the recruitment of start-up and unknown companies to the Johnson & Johnson Innovation Quick Pitch, we are launching a Quick Pitch Recruitment Program.

That's where you come in! If you know a company that you think might be interested in presenting to leadership from the Johnson & Johnson Family of Companies at the J.P. Morgan Healthcare conference, you could be eligible for a recruitment payment of $3,000. 

Here’s how it works:  refer an applicant to the Quick Pitch and have the applicant identify you as the recruiting source in the Quick Pitch application. If the applicant is selected and pitches to Johnson & Johnson leadership at the 2019 J.P. Morgan Healthcare conference, you may be eligible for the recruitment payment.

Please find complete details about eligibility for the Quick Pitch Recruitment Program as well as an associated privacy notice in the FAQ below

Areas of Interest

We encourage applications from companies working on all aspects of human healthcare, and have a particular interest in the following areas:


  • CAR-T and other immune cell therapy
  • Gene therapy
  • RNAi targeting and delivery approaches
  • Gene editing
  • Armed antibodies and other multi-specific biologics
  • Data Science platforms and tools
  • Retinal Diseases
Medical Devices
  • Digital Surgery (including Orthopedics, General Surgery and CSS)
    • Wearable and implantable sensors
    • Artificial Intelligence
    • AV/VR/MR
    • Advanced Imaging and Visualization
    • Robotics and Automation
    • Perioperative care/Care coordination
  • Infection
    • Prevention and Treatment in Surgery and Orthopedics
  • Tissue Regeneration
    • Scaffolds and new implantable materials
    • Biologics and growth factors
    • Early intervention in Osteoarthritis, Degenerative Disc Disease and Osteoporosis
  • General Surgery Solutions
    • Biological and synthetic technologies for stopping bleeding, sealing leaks
    • Technologies in tissue proximation and wound closure
    • Energy based technologies for surgery (cutting and coagulation) and tumor ablation
  • Interventional Solutions
    • Technologies for Neurovascular and Stroke Treatment
  • Digital selfcare solutions
    • Pain management
    • Menopause
    • Digestive health
    • Allergy
  • Healthy Skin
Vision Care
  • Restoring Accommodation
    • Optical/opto-mechanical designs
    • Shape changing materials
    • SMART technology
  • Progressive Myopia
    • Diagnostics to predict fast vs. slow progression
    • Genetic predictors
    • Technologies to slow axial growth
  • Cataract Surgery
    • Eliminate post-operative residual refractive error 
    • Prevention of posterior capsular opacification
    • Alternative energy approaches for cataract extraction
    • Office-based cataract surgery
  • Soft Contact Lenses with Added  Functionality
    • AR, biosensors
    • Rx treatment delivery.
    • Novel materials/coatings that improve end-of-day comfort
  • Dry Eye Disease: 
    • Pharmaceuticals in late stage development
    • Biomarkers for diagnosis and drug targets
    • Drug delivery
  • Technologies for Macular Degeneration 
    • Low vision optical designs
    • Optical designs that improve off-axis image quality
    • AR/VR, visual aids, SMART technology
  • Digital Cataract Surgery
    • Artificial Intelligence
    • AV/VR/MR
    • Advanced Imaging and Visualization
    • Robotics and Automation
Cross Sector Lung Cancer
  • Digital Therapeutics for Lung Cancer prevention or interception
  • Anti-inflammatory solutions for Lung Cancer prevention or interception
Global Public Health
  • Ways to improve detection of MDR-TB, particularly in High-Burden Countries
  • Approaches for shutting down the respiratory chain of the tuberculosis bacterium


Application process

Applicants will be required to submit a design. Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:

  • Potential impact
  • Uniqueness of solution & level of competition in current market
  • Quality & feasibility of technology
  • Team credibility & capabilities
  • 5 minute pitch presentation to Johnson & Johnson Innovation 's leadership
  • 5 minute Q&A with Johnson & Johnson Innovation's leadership
  • Applications open: November 14
  • Applications close: December 7
Why this opportunity matters to us

At Johnson & Johnson, we believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that provide solutions to patients from across the world. Working together, we can spark the next great idea that will change the trajectory of health.

About Johnson & Johnson Innovation

About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of 3 businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life-science start-ups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit:


Is there a monetary award for this Quick Pitch?
There is no monetary award. This is just an opportunity to present your innovation to Johnson & Johnson Innovation's leadership.

If I’m invited to present, will Johnson & Johnson cover travel related expenses?
No, travel is not covered as part of the Quick Pitch.

Is it ok if some of the information I submit is confidential?
No. Please do not submit confidential information. Only non-confidential information should be submitted and anything you submit will be treated as non-confidential

Can I submit supporting documents (for example a video) as part of my application?
You will have the opportunity and are encouraged to upload supporting materials such as slide decks, research papers, and videos as part of your application.

Is a patent required to apply?
No, a patent is not required to apply.However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.

How does the Quick Pitch Recruitment Program work?
Refer an applicant to the Quick Pitch and have the applicant identify you as the recruiting source in the Quick Pitch application. If the applicant is selected and pitches to Johnson & Johnson leadership at the 2019 J.P. Morgan Healthcare conference, you may be eligible for the $3000 recruitment payment. All recruitment payments will be paid after the 2019 J.P. Morgan Healthcare conference.

Please note that applicants must provide the name and email address of their referral source in order to be eligible for the recruitment program.

Privacy notice: By advertising to your network, you acknowledge and consent to an applicant identifying you by providing your name and contact information to J&J Innovation for the sole purpose of contacting you to determine your recruitment payment eligibility and, if eligible, to be provided the recruitment payment. We will use your information in accordance with our Privacy Policy.

You are also consenting to the transfer of your information to countries outside of your country of residence, including the United States, which may provide for different data protection rules than in your country. You may withdraw your consent at any time.

Is everyone eligible for the Quick Pitch Recruitment Program ?

  • Healthcare professionals and government officials/employees are not eligible for a recruitment payment.
  • An individual cannot recommend himself/herself or his/her company.
  • If an individual is not able to receive funding from industry per his/her institution’s policies, then the recruitment fee will not be provided.
  • J&J employees and their families are not eligible to receive the recruitment payment


How do you define a Healthcare professional and government officials/employees?
Government Official or “GO” means any official or employee of a government agency or instrumentality of the government including but is not limited to a political party, party official or candidate, or public international organizations. It also includes individuals representing himself or herself as a GO, for example, a customs official, inspector, auditor, investigator, elected official, or employee of a government ministry or agency. Note that this definition includes agents or employees of some non-governmental (NGO) organizations where those organizations perform quasi-governmental services such as distribution of drugs and medical devices or delivery of health care services, an individual who is an agent or consultant to a government agency, or provides a primary business address at a government facility, uses a military title or rank, supplies an email address associated with a government entity or is otherwise known or believed to be a government employee. Health Ministries and government-owned hospitals often employ HCPs who may be GOs under local law. A private HCP that provides consulting services or otherwise acts as an agent of the government, these individuals should be considered Government Officials.
“Health Care Professionals” or “HCPs” means:

  • All physicians; and
  • Any other individual, institution or entity with the ability to prescribe, acquire or influence the prescription or acquisition of the Johnson & Johnson (including its affiliates and subsidiaries) products or services at issue, and either of the following:
    • The products at issue are regulated or registered as medicinal products or devices (or their equivalents) in the applicable country; or
    • The products or services at issue are subject to reimbursement by government or third parties; or, are offered for sale with products or services subject to such reimbursement

Examples of HCPs -- depending on the nature of the products or services at issue -- may include, but are not limited to, doctors, nurses, physician assistants, pharmacists, other para-medical staff, members of product formulary committees, health economists, key opinion leaders including scientists and/or PhD’s, clinical investigators and researchers, administrative and management employees of private and public hospitals, HCPs-in-training and medical societies.